Advanced Search
ZHAI Jianpo, WANG Jianwei, WANG Haidong, MAN Libo. Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1129-1133. DOI: 10.3971/j.issn.1000-8578.2014.10.016
Citation: ZHAI Jianpo, WANG Jianwei, WANG Haidong, MAN Libo. Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1129-1133. DOI: 10.3971/j.issn.1000-8578.2014.10.016
shu

Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer

    Abstract
  • Muscle-invasive bladder cancer ( MIBC ) refers to the bladder cancer with clinical stage cT2-cT4a. Radical cystectomy with pelvic lymph node dissection is considered as the gold standard treatment for MIBC, but the 5-year survival after cystectomy varies widely. Neoadjuvant chemotherapy could improve the 5-year survival of MIBC. This article reviews the optimal chemotherapy regimens, current status and future issues of the neoadjuvant chemotherapy.
    • FullText(HTML)
  • loading
    • References (33)
    • Related Articles

Catalog

    Turn off MathJax
    Article Contents

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits： Visits today：

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return